![](https://cc-tdi.org/wp-content/uploads/2023/05/IMG_9927-1-225x300.jpg)
Newly Published Studies Suggest a Framework for RMS Drug Development
We are thrilled to announce a new publication, Structure-activity relationship of dihydropyridines for rhabdomyosarcoma, showcasing results of a study of a massive drug & chemical
We are thrilled to announce a new publication, Structure-activity relationship of dihydropyridines for rhabdomyosarcoma, showcasing results of a study of a massive drug & chemical
We are thrilled to announce a new publication, Structure-activity relationship of dihydropyridines for rhabdomyosarcoma, showcasing results of a study of a massive drug & chemical
EIN: 46-5759569
cc-TDI is a qualified 501(c)(3) charitable organization registered with the IRS
(consult with a CPA regarding specific tax implications)
Copyright 2023 – Children’s Cancer Therapy Development Institute